Celsion Corporation Adds Key Resources to its Vaccine Development Initiative and Clinical Trial Capabilities
October 05, 2021 09:00 ET
|
Celsion CORP
LAWRENCEVILLE, N.J., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines,...